SARS-CoV-2 Spike protein RBD-HRP, BA.2 variant, His Tag
SARS-CoV-2 Spike Protein RBD-HRP, BA.2 Variant, His Tag

SARS-CoV-2 Spike protein RBD-HRP, BA.2 Variant, His Tag (Cat.No. Z03741) can bind with ACE2 in functional ELISA assay.

SARS-CoV-2 Spike protein RBD-HRP, BA.2 variant, His Tag

BA.2 differs from BA.1 in its genetic sequence, including some amino acid differences in the spike protein and other proteins. Studies have shown that BA.2 has a growth advantage over BA.1. Studies are ongoing to understand the reasons for this growth advantage, but initial data suggest that BA.2 appears inherently more transmissible than BA.1, which currently remains the most common Omicron sublineage reported. This difference in transmissibility appears to be much smaller than, for example, the difference between BA.1 and Delta. Further, although BA.2 sequences are increasing in proportion relative to other Omicron sublineages (BA.1 and BA.1.1), there is still a reported decline in overall cases globally.
Z03741
¥21,750.00

Ask us a question
Product Introduction
Species SARS-CoV-2
Protein Construction

Expressed with the mutations of G339D, S371F, S373P, S375F, T376A, D405N, R408S, K417N, N440K, S477N, T478K, E484A, Q493R, Q498R, N501Y, Y505H.

Spike RBD (Arg319-Phe541)
Accession # P0DTC2		 Poly-His
N-term C-term
Conjugate HRP
Biological Activity This protein is validated to bind with human ACE2 (Z03516) in functional ELISA assay.
Expression System Human Cells
Application The optimal dilution ratio should be determined by the end user for specific applications.
ELISA 1:1000
Formulation Supplied as a solution in PBS, pH 7.4, 0.1% ProClin 300.
Storage & Stability Upon receiving, this product remains stable for up to 3 months at 2-8 °C. Protect from light.

Examples
  • SARS-CoV-2 Spike Protein RBD-HRP, BA.2 Variant, His Tag
    • SARS-CoV-2 Spike Protein RBD-HRP, BA.2 Variant, His Tag

    SARS-CoV-2 Spike protein RBD-HRP, BA.2 Variant, His Tag (Cat.No. Z03741) can bind with ACE2 in functional ELISA assay.


Background
Target Background The Omicron variant of concern is currently the dominant variant circulating globally, accounting for nearly all sequences reported to GISAID. Omicron is made up of several sublineages, each of them being monitored by WHO and partners. Of them, the most common ones are BA.1, BA.1.1 (or Nextstrain clade 21K) and BA.2 (or Nextstrain clade 21L). At a global level, the proportion of reported sequences designated BA.2 has been increasing relative to BA.1 in recent weeks, however the global circulation of all variants is reportedly declining. BA.2 differs from BA.1 in its genetic sequence, including some amino acid differences in the spike protein and other proteins. Studies have shown that BA.2 has a growth advantage over BA.1. Studies are ongoing to understand the reasons for this growth advantage, but initial data suggest that BA.2 appears inherently more transmissible than BA.1, which currently remains the most common Omicron sublineage reported. This difference in transmissibility appears to be much smaller than, for example, the difference between BA.1 and Delta. Further, although BA.2 sequences are increasing in proportion relative to other Omicron sublineages (BA.1 and BA.1.1), there is still a reported decline in overall cases globally.
Synonyms BA.2; Omicron variant
References 1. Statement on Omicron sublineage BA.2
2. 'Stealth' Omicron Is Stealthy No More: What's Known About the BA.2 Variant

For laboratory research use only. Direct human use, including taking orally and injection and clinical use are forbidden.